61
Views
17
CrossRef citations to date
0
Altmetric
Review

Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response

&
Pages 261-268 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lu Zhang, Qiu-Yan Chen, Huai Liu, Lin-Quan Tang & Hai-Qiang Mai. (2013) Emerging treatment options for nasopharyngeal carcinoma. Drug Design, Development and Therapy 7, pages 37-52.
Read now

Articles from other publishers (16)

Adam Hermawan & Herwandhani Putri. (2023) Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer. Beni-Suef University Journal of Basic and Applied Sciences 12:1.
Crossref
Elif EĞİLMEZ, Cemile ZONTUL, Alakbar HUSEYNZADA, Gunel ALİYEVA, Ulviyya HASANOVA, Ayça TAŞ & Yavuz SİLİĞ. (2022) INVESTIGATION OF THE EFFECT OF B-108 CONTAINING AZOMETHIN GROUP ON DNA REPAIR GENE. Cumhuriyet Medical Journal.
Crossref
Chao Wang, Xiao-Wen Liu, Ting Xiao, Zhi-Qiang Xu, Shuang Cao, Hai-Feng Wang, Qiong-Jiao Yan, Shuang-Xi Gu & Yuan-Yuan Zhu. (2020) Anticancer activity evaluation of indazolyl-substituted piperidin-4-yl-aminopyrimidines. Medicinal Chemistry Research 29:5, pages 910-915.
Crossref
Xiangdong Wang, Yong Zhang, Carol L. Nilsson, Frode S. Berven, Per E. Andrén, Elisabet Carlsohn, Peter Horvatovich, Johan Malm, Manuel Fuentes, Ákos Végvári, Charlotte Welinder, Thomas E. Fehniger, Melinda Rezeli, Goutham Edula, Sophia Hober, Toshihide Nishimura & György Marko-Varga. (2015) Association of chromosome 19 to lung cancer genotypes and phenotypes. Cancer and Metastasis Reviews 34:2, pages 217-226.
Crossref
William W. Lockwood, Ian M. Wilson, Bradley P. Coe, Raj Chari, Larissa A. Pikor, Kelsie L. Thu, Luisa M. Solis, Maria I. Nunez, Carmen Behrens, John Yee, John English, Nevin Murray, Ming-Sound Tsao, John D. Minna, Adi F. Gazdar, Ignacio I. Wistuba, Calum E. MacAulay, Stephen Lam & Wan L. Lam. (2012) Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development. PLoS ONE 7:5, pages e37775.
Crossref
Lawton J Stubbert, Jennifer M Smith & Bruce C McKay. (2010) Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin. BMC Cancer 10:1.
Crossref
Ming-Yue Li, Huiling Yuan, Lily T. Ma, Angel W. Y. Kong, Michael K. Y. Hsin, Johnson H. Y. Yip, Malcolm J. Underwood & George G. Chen. (2010) Roles of Peroxisome Proliferator–Activated Receptor–α and –γ in the Development of Non–Small Cell Lung Cancer. American Journal of Respiratory Cell and Molecular Biology 43:6, pages 674-683.
Crossref
Ming-Yue Li, Jackie Leung, Angel W. Y. Kong, Nian Ci Liang, Kefeng Wu, Michael K. Y. Hsin, Yi Feng Deng, Xianling Gong, Yingnian Lv, Tony S. K. Mok, Malcolm J. Underwood & George G. Chen. (2010) Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells. Journal of Molecular Medicine 88:12, pages 1265-1276.
Crossref
Albiruni R.A. Razak, Lillian L. Siu, Fei-Fei Liu, Emma Ito, Brian O’Sullivan & Kelvin Chan. (2010) Nasopharyngeal carcinoma: The next challenges. European Journal of Cancer 46:11, pages 1967-1978.
Crossref
Giovanna E. Carpagnano, Grazia P. Palladino, C. Gramiccioni, Maria P. Foschino Barbaro & D. Martinelli. (2010) Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients. Lung Cancer 68:2, pages 305-307.
Crossref
William R. Wilson, Stephen M. Stribbling, Frederik B. Pruijn, Sophie P. Syddall, Adam V. Patterson, H.D. Sarath Liyanage, Eileen Smith, K. Jane Botting & Moana Tercel. (2009) Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N 3 DNA minor groove alkylators . Molecular Cancer Therapeutics 8:10, pages 2903-2913.
Crossref
XiaoJuan Sun, Jeffrey D. Ritzenthaler, XiaoRong Zhong, Ying Zheng, Jesse Roman & ShouWei Han. (2009) Nicotine Stimulates PPARβ/δ Expression in Human Lung Carcinoma Cells through Activation of PI3K/mTOR and Suppression of AP-2α. Cancer Research 69:16, pages 6445-6453.
Crossref
Emilio Esteban, Marta Casillas & Alejo Cassinello. (2009) Pemetrexed in first-line treatment of non-small cell lung cancer. Cancer Treatment Reviews 35:4, pages 364-373.
Crossref
ShouWei Han, Jeffrey D. Ritzenthaler, XiaoJuan Sun, Ying Zheng & Jesse Roman. (2009) Activation of Peroxisome Proliferator–Activated Receptor β/δ Induces Lung Cancer Growth via Peroxisome Proliferator–Activated Receptor Coactivator γ-1α. American Journal of Respiratory Cell and Molecular Biology 40:3, pages 325-331.
Crossref
Chiara Arienti, Anna Tesei, Alberto Ravaioli, Marina Ratta, Silvia Carloni, Serena Mangianti, Paola Ulivi, Stefania Nicoletti, Dino Amadori & Wainer Zoli. (2008) Activity of lipoplatin in tumor and in normal cells in vitro. Anti-Cancer Drugs 19:10, pages 983-990.
Crossref
ShouWei Han, Jeffrey D. Ritzenthaler, Ying Zheng & Jesse Roman. (2008) PPARβ/δ agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-κB signals. American Journal of Physiology-Lung Cellular and Molecular Physiology 294:6, pages L1238-L1249.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.